Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ajbani

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in IndiaS B Georghiou, K Ajbani, C Rodrigues, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2011
Totally drug-resistant tuberculosis in IndiaZarir F Udwadia, Rohit A Amale, Kanchan K Ajbani, et al.
The Lancet. Infectious Diseases|October 26, 2013
Nomenclature of drug-resistant tuberculosisZarir F Udwadia, Rohit A Amale, Kanchan K Ajbani, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 28, 2014
Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in MumbaiM Kazi, L Drego, C Nikam, et al.
Indian Journal of Medical Microbiology|July 9, 2009
Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centreC Rodrigues, S Shenai, M Sadani, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2012
Can inhA mutation predict ethionamide resistance?V Vadwai, K Ajbani, M Jose, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 14, 2015
Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutationsP Kambli, K Ajbani, C Nikam, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Redefining MTBDRplus test results: what do indeterminate results actually mean?C Nikam, R Patel, M Sadani, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 17, 2016
A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosisM Seifert, K Ajbani, S B Georghiou, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2019
Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testingN A Ismail, H M Said, C Rodrigues, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Performance of a pyrosequencing platform in diagnosing drug-resistant extra-pulmonary tuberculosis in IndiaS B Georghiou, K Ajbani, C Rodrigues, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 23, 2011
Totally drug-resistant tuberculosis in IndiaZarir F Udwadia, Rohit A Amale, Kanchan K Ajbani, et al.
The Lancet. Infectious Diseases|October 26, 2013
Nomenclature of drug-resistant tuberculosisZarir F Udwadia, Rohit A Amale, Kanchan K Ajbani, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 28, 2014
Molecular characterization of carbapenem-resistant Enterobacteriaceae at a tertiary care laboratory in MumbaiM Kazi, L Drego, C Nikam, et al.
Indian Journal of Medical Microbiology|July 9, 2009
Evaluation of the bactec MGIT 960 TB system for recovery and identification of Mycobacterium tuberculosis complex in a high through put tertiary care centreC Rodrigues, S Shenai, M Sadani, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|November 14, 2012
Can inhA mutation predict ethionamide resistance?V Vadwai, K Ajbani, M Jose, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 14, 2015
Determination of MICs of levofloxacin for Mycobacterium tuberculosis with gyrA mutationsP Kambli, K Ajbani, C Nikam, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 22, 2016
Redefining MTBDRplus test results: what do indeterminate results actually mean?C Nikam, R Patel, M Sadani, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 17, 2016
A performance evaluation of MTBDRplus version 2 for the diagnosis of multidrug-resistant tuberculosisM Seifert, K Ajbani, S B Georghiou, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|May 18, 2019
Multicentre study to establish interpretive criteria for clofazimine drug susceptibility testingN A Ismail, H M Said, C Rodrigues, et al.
Pageof 2